Literature DB >> 13211819

The glucagon content of crystalline insulin preparations.

A STAUB, O K BEHRENS.   

Abstract

Entities:  

Keywords:  INSULIN; PANCREAS/hormones

Mesh：

Substances：

Year:  1954        PMID： 13211819      PMCID： PMC1072594          DOI： 10.1172/JCI103043

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  [Hyperglycemic and glycogenolytic pancreatic nucleoprotein].

Authors:  G MOHNIKE; H BOSER
Journal:  Z Gesamte Exp Med       Date:  1954

2.  Effect of glucagon on insulin hypoglycemia.

Authors:  M A ROOT; J ELLIS; A STAUB
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

3.  Partition chromatography of insulin and other proteins.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

4.  Endocrine regulation of the blood sugar.

Authors:  J W CONN
Journal:  Ann Intern Med       Date:  1953-02       Impact factor: 25.391

5.  Purification and crystallization of hyperglycemic glycogenolytic factor (HGF).

Authors:  A STAUB; L SINN; O K BEHRENS
Journal:  Science       Date:  1953-06-05       Impact factor: 47.728
  5 in total
  10 in total

1.  [GLUCAGON-SENSITIVE LIPOLYTIC ACTIVITY IN FATTY TISSUE].

Authors:  K F WEINGES; G LOEFFLER
Journal:  Klin Wochenschr       Date:  1965-02-01

2.  [The effect of glucagon and insulin on the metabolism of nonesterified fatty acids in isolated fatty tissue of the rat in vitro].

Authors:  K F WEINGES
Journal:  Klin Wochenschr       Date:  1961-03-15

3.  [On the effect of insulin and glucagon on glucose metabolism of the epididymal fat appendix of rats in vitro. II. The effect of glucagon in comparison with the effect of insulin].

Authors:  H WOERNER; K F WEINGES
Journal:  Klin Wochenschr       Date:  1961-03-01

4.  The significance of glucagon.

Authors:  G A WRENSHALL
Journal:  Can Med Assoc J       Date:  1956-06-01       Impact factor: 8.262

5.  The effect of glucagon on the blood glucose level and the clinical state in the presence of marked insulin hypoglycemia.

Authors:  S E GREBEN; J L SCHULMAN
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

Review 6.  Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.

Authors:  Melanie A Jackson; Nicholas Caputo; Jessica R Castle; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

7.  Biological assay of glucagon in rabbits.

Authors:  F Tarding; P Nielsen; B Keiser-Nielsen; A V Nielsen
Journal:  Diabetologia       Date:  1969-06       Impact factor: 10.122

8.  The physiological effect of glucagon on fat-mobilisation.

Authors:  P Lefebvre
Journal:  Diabetologia       Date:  1966-09       Impact factor: 10.122

9.  The Fourth International Standard for insulin.

Authors:  D R BANGHAM; M V MUSSETT
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

Review 10.  Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.

Authors:  Stephanie T Chung; Morey W Haymond
Journal:  J Diabetes Sci Technol       Date:  2014-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.